Oseltamivir-induced neuropsychiatric symptoms

Arshad Basha Shaik, Mukhyaprana Prabhu, Smita Shenoy, Sereen Rose Thomson

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


Oseltamivir is a viral neuraminidase enzyme inhibitor commonly prescribed for prevention and management of influenza. Common adverse effects of oseltamivir are gastrointestinal side effects such as nausea, vomiting, diarrhea, and pain abdomen; others are headache, insomnia, cough, skin rashes, and sadness. In 2006, US Food and Drug Administration added a warning to the label of oseltamivir drawing attention to the risk of developing neuropsychiatric adverse events (NPAE). However, the incidence of NPAE with oseltamivir has been underreported in India. Hence, in our report, we present the occurrence of neuropsychiatric symptoms such as aggressive behavior, restlessness, hallucinations, paranoid ideas, and insomnia following administration of oseltamivir in a young adult female patient.

Original languageEnglish
Pages (from-to)43-45
Number of pages3
JournalJournal of Pharmacology and Pharmacotherapeutics
Issue number1
Publication statusPublished - 01-01-2018

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Oseltamivir-induced neuropsychiatric symptoms'. Together they form a unique fingerprint.

Cite this